Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Elnaz Saberi"'
Autor:
David Gentien, Elnaz Saberi-Ansari, Nicolas Servant, Ariane Jolly, Pierre de la Grange, Fariba Némati, Géraldine Liot, Simon Saule, Aurélie Teissandier, Deborah Bourc’his, Elodie Girard, Jennifer Wong, Julien Masliah-Planchon, Erkan Narmanli, Yuanlong Liu, Emma Torun, Rebecca Goulancourt, Manuel Rodrigues, Laure Villoing Gaudé, Cécile Reyes, Matéo Bazire, Thomas Chenegros, Emilie Henry, Audrey Rapinat, Mylene Bohec, Sylvain Baulande, Radhia M’kacher, Eric Jeandidier, André Nicolas, Giovanni Ciriello, Raphael Margueron, Didier Decaudin, Nathalie Cassoux, Sophie Piperno-Neumann, Marc-Henri Stern, Johan Harmen Gibcus, Job Dekker, Edith Heard, Sergio Roman-Roman, Joshua J. Waterfall
Publikováno v:
Cell Reports, Vol 42, Iss 9, Pp 113132- (2023)
Summary: Uveal melanoma (UM) is a rare cancer resulting from the transformation of melanocytes in the uveal tract. Integrative analysis has identified four molecular and clinical subsets of UM. To improve our molecular understanding of UM, we perform
Externí odkaz:
https://doaj.org/article/1572404d6b2643f898a51a4a704e001b
Autor:
Elnaz Saberi Ansar, Changiz Eslahchii, Mahsa Rahimi, Lobat Geranpayeh, Marzieh Ebrahimi, Rosa Aghdam, Gwenneg Kerdivel
Publikováno v:
BMC Medical Genomics, Vol 12, Iss 1, Pp 1-14 (2019)
Abstract Background In 2012, Venet et al. proposed that at least in the case of breast cancer, most published signatures are not significantly more associated with outcome than randomly generated signatures. They suggested that nominal p-value is not
Externí odkaz:
https://doaj.org/article/e211c278123a47e0a51fe010300f9607
The Ability of Different Imputation Methods to Preserve the Significant Genes and Pathways in Cancer
Publikováno v:
Genomics, Proteomics & Bioinformatics, Vol 15, Iss 6, Pp 396-404 (2017)
Deciphering important genes and pathways from incomplete gene expression data could facilitate a better understanding of cancer. Different imputation methods can be applied to estimate the missing values. In our study, we evaluated various imputation
Externí odkaz:
https://doaj.org/article/00bbcc70c6384204bfd4454d3a0d0d47
Autor:
Gudrun Schleiermacher, Deborah A. Tweddle, Louis Chesler, Sally L. George, Olivier Delattre, Didier Surdez, Angel M. Carcaboso, Fariba Nemati, Didier Decaudin, Isabelle Janoueix-Lerosey, Cécile Pierre-Eugène, Maria Eugénia Marques Da Costa, Birgit Geoerger, Alexandra Saint-Charles, Elnaz Saberi-Ansari, Yasmine Iddir, Jaydutt Bhalshankar, Pierre Gestraud, Elaine Del Nery, Angharad Goodman, Simran Dhariwal, J. Ciaran Hutchinson, Sumana Shrestha, Karen Barker, Barbara Martins Da Costa, Yann Jamin, Evon Poon, Harvey Che, Qiong Gao, Elizabeth Calton, Chiara Gorrini, Angela Bellini, Lindi Chen, Irene Jiménez, Elizabeth R. Tucker
Cell line growth curves and PDX data for idasanutlin combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ade0a51c8dfce371b3bd0d4b0a103fc
https://doi.org/10.1158/1078-0432.22494934.v1
https://doi.org/10.1158/1078-0432.22494934.v1
Autor:
Gudrun Schleiermacher, Deborah A. Tweddle, Louis Chesler, Sally L. George, Olivier Delattre, Didier Surdez, Angel M. Carcaboso, Fariba Nemati, Didier Decaudin, Isabelle Janoueix-Lerosey, Cécile Pierre-Eugène, Maria Eugénia Marques Da Costa, Birgit Geoerger, Alexandra Saint-Charles, Elnaz Saberi-Ansari, Yasmine Iddir, Jaydutt Bhalshankar, Pierre Gestraud, Elaine Del Nery, Angharad Goodman, Simran Dhariwal, J. Ciaran Hutchinson, Sumana Shrestha, Karen Barker, Barbara Martins Da Costa, Yann Jamin, Evon Poon, Harvey Che, Qiong Gao, Elizabeth Calton, Chiara Gorrini, Angela Bellini, Lindi Chen, Irene Jiménez, Elizabeth R. Tucker
Supplementary methods, supplementary tables, supplementary figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::469607ba4ba88232995ac733d8951161
https://doi.org/10.1158/1078-0432.22494931
https://doi.org/10.1158/1078-0432.22494931
Autor:
Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, Barbara Martins Da Costa, Karen Barker, Sumana Shrestha, J. Ciaran Hutchinson, Simran Dhariwal, Angharad Goodman, Elaine Del Nery, Pierre Gestraud, Jaydutt Bhalshankar, Yasmine Iddir, Elnaz Saberi-Ansari, Alexandra Saint-Charles, Birgit Geoerger, Maria Eugénia Marques Da Costa, Cécile Pierre-Eugène, Isabelle Janoueix-Lerosey, Didier Decaudin, Fariba Nemati, Angel M. Carcaboso, Didier Surdez, Olivier Delattre, Sally L. George, Louis Chesler, Deborah A. Tweddle, Gudrun Schleiermacher
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
BackgroundALKactivating mutations are identified in approximately 10% of newly diagnosed neuroblastomas andALKamplifications in a further 1-2% of cases. Lorlatinib, a third generation ALK inhibitor, will soon be given alongside induction chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c1dd7dcadc124db0c0f97f550800dfe
https://pubmed.ncbi.nlm.nih.gov/36602782
https://pubmed.ncbi.nlm.nih.gov/36602782
Autor:
Apurva Gopisetty, Aniello Federico, Didier Surdez, Yasmine Iddir, Sakina Zaidi, Alexandra Saint-Charles, Joshua Waterfall, Elnaz Saberi-Ansari, Justyna Wierzbinska, Andreas Schlicker, Norman Mack, Benjamin Schwalm, Christopher Previti, Lena Weiser, Ivo Buchhalter, Anna-Lisa Böttcher, Martin Sill, Robert Autry, Frank Estermann, David Jones, Richard Volckmann, Danny Zwijnenburg, Angelika Eggert, Olaf Heidenreich, Fatima Iradier, Irmela Jeremias, Heinrich Kovar, Jan-Henning Klusmann, Klaus-Michael Debatin, Simon Bomken, Petra Hamerlik, Maureen Hattersley, Olaf Witt, Louis Chesler, Alan Mackay, Johannes Gojo, Stefano Cairo, Julia Schueler, Johannes Schulte, Birgit Geoerger, Jan J. Molenaar, David J. Shields, Hubert N. Caron, Gilles Vassal, Louis F. Stancato, Stefan M. Pfister, Natalie Jaeger, Jan Koster, Marcel Kool, Gudrun Schleiermacher
Publikováno v:
Cancer Research. 83:234-234
Advancements in state-of-the-art molecular profiling techniques have resulted in better understanding of pediatric cancers and driver events. It has become apparent that pediatric cancers are significantly more heterogeneous than previously thought a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9f689ca14428d824522f9a30f511100
https://doi.org/10.1158/1538-7445.am2023-234
https://doi.org/10.1158/1538-7445.am2023-234
Autor:
Apurva Gopisetty, Aniello Federico, Didier Surdez, Elnaz Saberi-Ansari, Yasmine Iddir, Alexandra Saint-Charles, Joshua Waterfall, Justyna Wierzbinska, Andreas Schlicker, Norman Mack, Benjamin Schwalm, David T Jones, Johannes Gojo, Louis Chesler, Gilles Vassal, Lou Stancato, Jan Koster, Jan J Molenaar, Natalie Jaeger, Gudrun Schleiermacher, Stefan Pfister, Marcel Kool
Publikováno v:
Neuro-Oncology. 24:vii126-vii127
Advancements in state-of-the-art molecular profiling techniques has resulted in better understanding of pediatric cancers and their drivers. Conversely, it also became apparent that pediatric cancers are much more heterogeneous than previously though
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c43a31fe055855349266fd37f77f0de
https://doi.org/10.1093/neuonc/noac209.481
https://doi.org/10.1093/neuonc/noac209.481
Autor:
David Gentien, Elnaz Saberi-Ansari, Nicolas Servant, Ariane Jolly, Pierre de la Grange, Fariba Némati, Géraldine Liot, Simon Saule, Aurélie Teissandier, Deborah Bourchis, Elodie Girard, Jennifer Wong, Julien Masliah Planchon, Manuel Rodrigues, Laure Villoing Gaudé, Cécile Reyes, Matéo Bazire, Thomas Chenegros, Mylene Bohec, Sylvain Baulande, Radhia M’kacher, Eric Jeandidier, André Nicolas, Didier Decaudin, Nathalie Cassoux, Sophie Piperno-Neumann, Marc-Henri Stern, Johan Harmen Gibcus, Job Dekker, Edith Heard, Sergio Roman-Roman, Joshua J. Waterfall
Uveal Melanoma (UM) is a rare cancer resulting from transformation of melanocytes residing in the uveal tract. Integrative analysis has identified four molecular and clinical subsets in UM. To improve our molecular understanding of UM we performed ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4c7f7b2be53fdf24b2f784d391c339e
https://doi.org/10.1101/2022.03.11.483767
https://doi.org/10.1101/2022.03.11.483767
Publikováno v:
Journal of the Endocrine Society. 6:A326-A326
Background Metformin is the first line of treatment for patients with Diabetes Mellitus type 2. Despite multiple benefits, metformin is contraindicated in stage 4 renal disease due to an increased risk of metformin associated lactic acidosis (MALA).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::763db8969f70d0bdf8a885bf5053064f
https://doi.org/10.1210/jendso/bvac150.675
https://doi.org/10.1210/jendso/bvac150.675